Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01600261 · ClinicalTrials.gov registry record
iCam Clinical Validation Study
A clinical trial, sponsored by Optovue.
- Completed
- Registry status
- 131
- Enrollment target
NCT01600261: Completed study, sponsored by Optovue.
NCT01600261 is a clinical trial that has completed, run by Optovue. The registered enrollment target is 131 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01600261 has completed, sponsored by Optovue.
- COMPLETED
- Registry status
- 131 participants
- Enrollment target
Study Summary
Comparison study to assess photo image quality of a new color fundus camera compared to that of a commercially available color fundus camera.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 131 participants |
| Start Date | 2012-04 |
| Est. Completion | 2012-06 |
What the finished NCT01600261 record still lists
NCT01600261 is an observational study that tracks outcomes without assigning an intervention. The registered 131 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01600261 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01600261 about?
NCT01600261 is a clinical study titled "iCam Clinical Validation Study". Comparison study to assess photo image quality of a new color fundus camera compared to that of a commercially available color fundus camera.
What is the current status of trial NCT01600261?
This trial is currently completed. The enrollment target is 131 participants. The study started on 2012-04. Estimated completion is 2012-06.
Who is sponsoring clinical trial NCT01600261?
This trial is sponsored by Optovue, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03051464 · 131 participants · Phase 2
No Surgery Trial / Two Dose-escalation Strategies
- NCT04301843 · 131 participants · Phase 2
Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
- NCT04748549 · 131 participants · NA
Intraoperative VR for Older Patients Undergoing TKA
- NCT05951179 · 131 participants · Phase 2
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia